Alivo, Ruel B.

HRN: 29-11-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2026
CEFTRIAXONE 1G (VIAL)
06/09/2026
06/16/2026
IV
2gm
OD
Multiple Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: